Skip to main content
. 2021 Oct 20;12:752762. doi: 10.3389/fneur.2021.752762

Table 1.

Demographic and clinical features of subjects.

Mild WMH (n = 32) Moderate WMH (n = 24) Severe WMH (n = 30) p-value
Demographic data
Age (years) 63.69 ± 5.47 64.33 ± 6.65 66.43 ± 5.07 0.126a
Gender (male/female) 16/16 13/11 18/12 0.731b
Education (years) 10.78 ± 3.13 11.08 ± 3.69 9.10 ± 3.89 0.078a
Hypertension (yes/no) 6/26 17/7d 21/9e <0.001b
Diabetes (yes/no) 3/29 4/20 8/22 0.199b
Smoking history (yes/no) 5/27 7/17 10/20 0.250b
Drinking history (yes/no) 8/24 3/21 3/27 0.234b
MRI features
Gray matter volume (ml) 614.96 ± 38.54 615.65 ± 31.16 626.83 ± 57.33 0.517c
Framewise displacement 0.18 ± 0.16 0.18 ± 0.10 0.17 ± 0.08 0.957c
Cognitive performance
Global cognitive function 0.28 ± 0.69 0.32 ± 0.79 −0.56 ± 1.19e,f <0.001c
Processing speed 0.18 ± 0.88 0.26 ± 0.89 −0.39 ± 1.11 f 0.026c
Executive function 0.33 ± 0.76 0.20 ± 0.95 −0.52 ± 1.08e,f 0.001c
Episodic memory 0.34 ± 0.88 0.12 ± 1.00 −0.46 ± 0.98e,f 0.005c
Language 0.25 ± 0.85 0.09 ± 1.12 −0.33 ± 0.99 0.061c
a

Kruskal–Wallis test.

b

χ2 test.

c

One-way analysis of variance.

d

Significant difference between mild WMH and moderate WMH groups.

e

Significant difference between mild WMH and severe WMH groups.

f

Significant difference between moderate WMH and severe WMH groups.

WMH, white matter hyperintensities.